Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06561022 | Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping(abemaSNF1/3) | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT03256201 | Exercise and Nutrition to Improve Pancreatic Cancer Outcomes | unknown | N/A | 95 | University of OklahomaOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT04271527 |
| Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy |
| unknown |
| N/A |
| 626 |
| Shanghai East HospitalOTHER |
| 1 |
| Aug 16, 2024 |
| clinicaltrials |
| NCT05182866 | ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer | unknown | Phase 2 | 9 | Rakuten Medical, Inc.INDUSTRY | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05351502 | A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors | unknown | Phase 1 | 38 | Beyond Air Inc.INDUSTRY | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | unknown | Phase 1 | 48 | RemeGen Co., Ltd.INDUSTRY | 2 | Aug 16, 2024 | clinicaltrials |
| NCT01890590 | A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | unknown | N/A | 46 | Beth Israel Deaconess Medical CenterOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05222087 | PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study(PRIME_LUNG) | unknown | Phase 1 | 40 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05385250 | Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II(DACG-II) | unknown | N/A | 100 | Karen-Lise Garm SpindlerOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05597683 | Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy | unknown | N/A | 50 | Gangnam Severance HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05719779 | Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.(Ronco-Onco) | unknown | N/A | 35 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06475170 | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy | unknown | N/A | 60 | Northern Jiangsu People's HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06540027 | The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer | unknown | — | 80 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06556004 | Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients(Trimelvax001) | unknown | Phase 1 | 20 | University of ChileOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05570279 | PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark(PLAN-A) | unknown | — | 314 | Aarhus University HospitalOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05605379 | CML Pediatric ITK Response According to Molecular Identification at Diagnosis(CML Piramid) | unknown | — | 88 | University Hospital, BordeauxOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05873322 | Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma | unknown | — | 100 | Aarhus University HospitalOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06054867 | PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System | unknown | N/A | 22 | PROCEPT BioRoboticsINDUSTRY | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06116812 | The Effects of Laughter Yoga and Mindfulness-Based Stress Reduction (MBSR) Practices Applied to Women With Breast Cancer | unknown | N/A | 105 | Kafkas UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06327386 | The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer | unknown | — | 32 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06553638 | Evaluation of the Prognostic Impact of Decreased Serum beta2 Microglobulin in the First Year of Follow-up of Myeloproliferative Neoplasia (PRODIGE)(PRODIGE) | unknown | — | 50 | University Hospital, BrestOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06553846 | A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors | unknown | Phase 1 | 50 | Fudan UniversityOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT03658785 | Immunotherapy for the Treatment of Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT04524208 | A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3(CABONEN) | unknown | Phase 2 | 45 | Karsten GavenisOTHER | 2 | Aug 13, 2024 | clinicaltrials |
| NCT04682808 | A Study of FCN-338 in Patients With Chronic CLL/SLL | unknown | Phase 1 | 99 | Fochon Pharmaceuticals, Ltd.INDUSTRY | 1 | Aug 13, 2024 | clinicaltrials |
| NCT05684731 | Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer(K19017-004) | unknown | Phase 1 | 30 | Tongji HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT05833815 | Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | unknown | Phase 2 / Phase 3 | 56 | Banaras Hindu UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06463522 | Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 20 | Beijing 302 HospitalOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06486155 | Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining | unknown | — | 2,200 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06510738 | Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images | unknown | — | 700 | Yunnan Cancer HospitalOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06550063 | HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes(HERA) | unknown | — | 2,188 | St. James's Hospital, IrelandOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550583 | Screening for Early Cervical Cancer Detection | unknown | — | 200 | Assiut UniversityOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT06550947 | ALDOA Expression in Bladder Urothelial Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Aug 13, 2024 | clinicaltrials |
| NCT06551233 | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) | unknown | Phase 1 | 30 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Aug 13, 2024 | clinicaltrials |
| NCT02897297 | Myeloproliferative Neoplastic Diseases Observatory From Brest(OBENE) | unknown | — | 1,000 | University Hospital, BrestOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04513977 | Geriatric Oncology SuPportive Clinic for ELderly(GOSPEL) | unknown | N/A | 200 | Goh Wen YangOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04914741 | A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)(COALITION) | unknown | Phase 1 / Phase 2 | 80 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05244551 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 85 | Abbisko Therapeutics Co, LtdINDUSTRY | 2 | Aug 12, 2024 | clinicaltrials |
| NCT05805319 | Dietary Intervention for NSCLC Patients Treated With ICI | unknown | N/A | 80 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06248580 | Find HDV and Determine Its Status in Turkey(SITUHDVATION) | unknown | — | 20,000 | Yaşar Bayındır, MDOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06543264 | Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia | unknown | N/A | 60 | Delta University for Science and TechnologyOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT06548867 | Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib(CABOGEN) | unknown | — | 80 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT04696081 | Atrial Fibrillation in Active Cancer Patients(AFIB-CANCER) | unknown | — | 1,000 | University Hospital, CaenOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.(iMETABO) | unknown | — | 10 | British Columbia Cancer AgencyOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05266612 | Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors | unknown | Phase 1 | 12 | Virogin Biotech Canada LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05644457 | Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck(DART) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05645783 | Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion(ENHANCE) | unknown | — | 170 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05748093 | Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat(OSIBOOST 2) | unknown | Phase 4 | 60 | Maastricht University Medical CenterOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT05996263 | Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)(PEMBROMIC) | unknown | — | 75 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 19, 2024source: clinicaltrials